Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Warts 1Vomiting 1Peripheral Nervous System Diseases 1Nausea 1Lung Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

sagopilone 1pembrolizumab 1nabilone 1eribulin 1enfortumab vedotin 1allantoicase 1Prednisolone 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Lenalidomide 1Exercise 1Epoetin Alfa 1BID protein, human 1Acetylcarnitine 14-((3-(1,6-dihyro-6-oxo-9H-purin-9-yl)-1-oxopropyl)amino)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Peripheral Nervous System Diseases × Exercise × Clear all
NCT05488873 2024-07-22

A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy

WinSanTor, Inc

Phase 2 Active not recruiting
60 enrolled

Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡